Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06077838 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

RELAXaHEAD for Headache Patients (Phase III)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment increased: 356 → 450 participants Eligibility criteria expanded, about 14 words · Secondary endpoints: details revised at 1 of 2 entries Show 2 more changesShow less
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 2 entries
  2. Re-verified, no change to tracked fieldsv5
  3. Start date: Jan 10, 2024 to Nov 8, 2023v4
  4. Start date: Nov 6, 2023 to Jan 10, 2024 Primary and study completion dates: Dec 2028 to Aug 31, 2028v3 Show 1 more changeShow less
    • Primary and study completion dates: Dec 2028 to Aug 31, 2028
  5. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 2023 to Nov 6, 2023 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Oct 2023 to Nov 6, 2023
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
NYU Langone Health
397 trials monitored
See 18 trials at risk
Migraine
467 trials monitored
See 24 trials at risk
This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.
Trial Details
NCT Number NCT06077838
Lead Sponsor NYU Langone Health
Collaborators: National Institutes of Health (NIH)
Conditions Migraine
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov